ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0970

Hippo Signaling Is a Novel Regulator of Apoptosis and Photosensitivity in Lupus Keratinocytes

Grace Hile1, Patrick Coit2, Bin Xu1, Shannon Estadt1, Jacob Martens3, Rachael Wasikowski1, Lam Tsoi1, Ramiro Iglesias-Bartolome4, Celine Berthier1, Allison Billi5, Johann Gudjonsson5, Amr Sawalha2 and J. Michelle Kahlenberg1, 1University of Michigan, Ann Arbor, MI, 2University of Pittsburgh, Pittsburgh, PA, 3Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, MI, 4NIH, National Cancer Institute, Bethesda, MD, 5Department of Dermatology, University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2021

Keywords: Apoptosis, autoimmune diseases, Cutaneous, cutaneous lupus, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: SLE – Etiology & Pathogenesis (0970–0973)

Session Type: Abstract Session

Session Time: 2:00PM-2:15PM

Background/Purpose: Skin inflammation and photosensitivity are common manifestations of cutaneous (CLE) and systemic lupus erythematosus (SLE), yet the mechanisms underlying heightened cell death and epidermal inflammation remain unclear. Non-lesional lupus keratinocytes (KCs) sustain an interferon (IFN)-rich, inflammatory profile even through several weeks of culture, suggesting possible epigenetic changes that drive this phenotype. Here we identify differential methylation of the Hippo signaling pathway as a novel regulator of apoptosis and photosensitive responses in lupus skin.

Methods: Genome-wide DNA methylation analysis was performed on extracted KC DNA from SLE patients and HC skin biopsies. Single-cell and bulk RNA sequencing was used to analyze RNA expression in cultured primary KCs from SLE patients and HC.In vivo protein and phospho-protein expression was assessed by immunofluorescent staining of HC and non-lesional lupus skin. A spontaneously immortalized KC line (N/TERTs) expressing a tetracycline inducible TEAD inhibitor (TEADi) that prevents colocalization of YAP-TEAD was used to evaluate the role of YAP signaling in apoptosis and UVB-mediated cell death. Apoptosis was analyzed via TUNEL staining and caspase 3/7 assay.

Results: Genome-wide DNA methylation analysis on cultured KC DNA from non-lesional, non-sun exposed skin biopsies of SLE patients and HC identified Hippo signaling as the top differentially-methylated pathway. We found significant hypomethylation of WWC1 in lupus KCs compared to control (Δβ=-0.17,P= 4.36 X 10-9) which promotes phosphorylation and thus cytosolic sequestration of YAP, attenuating TEAD-mediated transcription of pro-proliferative target genes. To determine functional relevance, we compared IFNγ or IFNα stimulated RNA-seq samples from the KCs used for our methylation studies. We found a negative correlation between IFN responses and methylation signatures. As confirmation, we analyzed Hippo regulated genes using single-cell RNA sequencing of nonlesional KC isolated from skin biopsies of lupus vs. HC and found downregulation of pro-proliferative YAP target genes such as SLP1, MYC, and AREG. Consistent with modulation of Hippo signaling as predicted by our methylation data, WWC1 expression was significantly increased in SLE vs. HC KC (p = 0.0142). Further, immunofluorescent microscopy of frozen non-lesional biopsies identified a significant increase in phosphorylated YAP in lupus skin compared to controls. TEADi induction in a spontaneously immortalized KC line resulted in a robust increase in UVB-mediated apoptosis as measured by TUNEL staining and caspase 3/7 activation, suggesting that the cytoplasmic retention of YAP observed in SLE KCs may contribute to enhanced UV-mediated KC apoptosis.

Conclusion: Collectively, our work describes a novel mechanistic paradigm in lupus KC in which hypomethylation of key regulators of the Hippo pathway restrict coactivation of TEAD transcriptional activity through cytoplasmic retention of YAP. This results in a propensity for apoptosis after UVB. Thus, modulation of the Hippo pathway could serve as a novel target for abrogation of photosensitivity in SLE and CLE patients.

Figure 1: Deactivation of Hippo signaling in SLE KCs leads to increased UVB-mediated apoptosis. A. Illumina methylation arrays of non-lesional SLE vs. control KCs (age, sex, race matched, n=7 each) identified differential methylation in SLE KCs and B. KEGG analysis (via DAVID) revealed Hippo signaling as the top significantly differentially methylated pathway. C. Schematic of Hippo signaling in SLE KCs: increased WWC1 leads to phosphorylation of LATS1/2 which then phosphorylates YAP and leads to cytosolic retention and decreased transcription of proliferative genes and increased transcription of pro-apoptotic genes. D. Western blot of WWC1 and beta-actin in 3 healthy control and 3 SLE KC cultures. E. Quantification of WWC1 in 3 HC and 3 SLE KC lines. F. Immunofluorescent staining of healthy control and SLE non-lesional skin identifies increased phospho-YAP staining in SLE vs. HC. G. Quantification of pYAP in 3 SLE and 3 HC lines. H and I. Induction of a protein which interrupts YAP-TEAD binding results in increased UVB mediated apoptosis (treated with 50 mJ/cm2) as measured by TUNEL staining (H) and active caspase 3/7 (I)


Disclosures: G. Hile, None; P. Coit, None; B. Xu, None; S. Estadt, None; J. Martens, None; R. Wasikowski, None; L. Tsoi, None; R. Iglesias-Bartolome, None; C. Berthier, None; A. Billi, None; J. Gudjonsson, Almirall, 5, Eli Lilly, 5, BMS, 5; A. Sawalha, None; J. Kahlenberg, astrazeneca, 1, Janssen, 5, Bristol Myers Squibb, 1, 5, q32 Bio, 5, Ventus Therapeutics, 2, Eli Lilly, 1, GlaxoSmithKlein, 1.

To cite this abstract in AMA style:

Hile G, Coit P, Xu B, Estadt S, Martens J, Wasikowski R, Tsoi L, Iglesias-Bartolome R, Berthier C, Billi A, Gudjonsson J, Sawalha A, Kahlenberg J. Hippo Signaling Is a Novel Regulator of Apoptosis and Photosensitivity in Lupus Keratinocytes [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/hippo-signaling-is-a-novel-regulator-of-apoptosis-and-photosensitivity-in-lupus-keratinocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hippo-signaling-is-a-novel-regulator-of-apoptosis-and-photosensitivity-in-lupus-keratinocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology